Skip to content

A Prehabilitation Program to Boost Postoperative Functional Capacity in Surgical Lung Cancer Patients

A Prehabilitation Program to Boost Postoperative Functional Capacity in Surgical Lung Cancer Patients: a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04826835
Enrollment
198
Registered
2021-04-01
Start date
2021-05-14
Completion date
2025-06-01
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Prehabilitation, Physical activity, Lung resection, Functional capacity

Brief summary

This research study is evaluating a prehabiliation intervention designed to improve postoperative functional capacity (measured by 6-minure walking distance) in individuals undergoing lung resection for cancer.

Interventions

Participants will: * Receive four recorded health education talks (twice per week for two weeks) * Receive a brief health education booklet on dietary education for chronic lung conditions, preoperative preparation, and postoperative recovery * Receive usual care.

Participants will: * Receive four supervised exercise classes (twice per week for two weeks) one-to-one by an exercise specialist; * Practice six sessions of home-based exercise (three times per week for two weeks); * Practice unsupervised respiratory muscle training at home (twice daily for two weeks); * Receive usual care.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients who are diagnosed of stage I, II, or IIIA Non-small-cell lung carcinoma (NSCLC) diagnosis, with or without pre-operative histologic confirmation 2. Patients scheduled to undergo lung resection surgery at least two weeks from recruitment 3. Patients with a Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 at recruitment 4. Patients with no evidence of recurrent or progressive disease 5. Patients aged 45-80 years 6. Patients able to communicate in Cantonese, Mandarin, or English 7. Patients is absence of any cognitive impairment 8. Patients with a score of 6 minutes walking test (6MWT) ≤ 500 meters at baseline. \[rationale: a threshold value of 500 meters preoperative 6MWT predicts a higher risk of postoperative complications and prolonged LOS after lung resection\] 9. Engagement in less than 150 minutes of moderate aerobic activity per week in the past 3 months

Exclusion criteria

1. Patients who had engaged in at least 150 minutes of moderate aerobic activity or 75 minutes of vigorous aerobic activity per week in the past three months 2. Presence of another concurrent, actively treated malignancy 3. Presence of chronic obstructive pulmonary disease 4. Presence of significant comorbidities that impede ability to engage in exercise, such as congestive heart failure, orthopedic disorders of the lower limbs, respiratory failure, or the need for portable oxygen therapy for activities of daily living 5. Not having a smart device to receive WhatsApp messages

Design outcomes

Primary

MeasureTime frame
Change from baseline 6-minute walking distance from baseline to 3-month post-surgeryBaseline; 3-month post-surgery

Secondary

MeasureTime frame
Change from baseline 6-minute walking distance at 1-month post-surgeryBaseline; 1-months post-surgery
Length of postoperative hospital stay1-month post-surgery
Postoperative complication1-month post-surgery
Change from baseline functional assessment of cancer treatment - Lung (FACT-L) at post-interventionBaseline; 2 weeks (post-intervention)
Change from baseline functional assessment of cancer treatment - Lung (FACT-L) at 1-month post-surgeryBaseline; 2 weeks (post-intervention); 1-month post-surgery
Change from baseline functional assessment of cancer treatment - Lung (FACT-L) at 3-months post-surgeryBaseline; 3-month post-surgery
Change from baseline international physical activity questionnaire (IPAQ) at post-interventionBaseline; 2 weeks (post-intervention)
Change from baseline international physical activity questionnaire (IPAQ) at 1-month post-surgeryBaseline; 1-month post-surgery
Change from baseline 6-minute walking distance at post-interventionBaseline; 2 weeks (post-intervention)
Change from baseline daily step count measured by pedometer at post-interventionBaseline; 2 weeks (post-intervention)
Change from baseline daily step count measured by pedometer at 1-month post-surgeryBaseline; 1-month post-surgery
Change from baseline daily step count measured by pedometer at 3-month post-surgeryBaseline; 3-month post-surgery
Health-related quality of life for the cost-effectiveness analysis (EuroQol- 5 Dimension, EQ-5D-5L)Baseline; 2 weeks (post-intervention); 1-month post-surgery; 3-month post-surgery
Health-related quality of life for the cost-effectiveness analysis (EuroQol-Visual Analog Score, EQ-VAS)Baseline; 2 weeks (post-intervention); 1-month post-surgery; 3-month post-surgery
Physical activity self-efficacy (9-item Self-Efficacy for Exercise, SEE)Baseline; 2 weeks (post-intervention); 1-month post-surgery; 3-month post-surgery
Financial toxicity (COmprehensive Score for financial Toxicity, COST questionnaire)Baseline; 3-month post-surgery
Return to work (investigator-designed questionnaire)3-month post-surgery
Change from baseline international physical activity questionnaire (IPAQ) at 3-month post-surgeryBaseline; 3-month post-surgery

Countries

Hong Kong

Contacts

Primary ContactChia-chin Lin, PhD
cclin@hku.hk39176614
Backup ContactXinyi Xu, BSN
xuxinyi@connect.hku.hk39176948

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026